Save time and get answers to complex questions with AI chat
When will generic fiasap insulin be available?Patent expiration date of guselkumab?Patent tenofovir alafenamide gilead?What's the advised delay for milk post lipitor?When did risperdal constas patent expire published article?
Short answer: there are no FDA-approved oral Factor B inhibitors in the United States, so there are no branded products with an established US market price. What’s in development: - Iptacopan (LNP023) is the leading oral Factor B inhibitor in late-stage development for conditions like PNH and C3 glomerulopathy. It does not have an approved brand name in the US, and there is no publicly disclosed US price yet because it is not approved. - Other Factor B inhibitors are in early development or preclinical stages; none have an approved US brand or price. If you meant a different “Factor B” target (e.g., coagulation-related Factor B) or you’d like price information for other, approved therapies in related areas (like complement inhibitors that are available now), I can help with that. Would you like me to clarify which pathway you’re interested in or pull together current price information for comparable approved therapies?
Other Questions About Oral :